Laser Therapy for Pediatric Burn Scars
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02707627 |
Recruitment Status :
Recruiting
First Posted : March 14, 2016
Last Update Posted : November 20, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Cicatrix, Hypertrophic Burns | Device: Laser Therapy |
Study Type : | Observational |
Estimated Enrollment : | 54 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | A Controlled Trial Investigating the Use of Laser Therapy to Improve Pediatric Burn Scars. |
Study Start Date : | October 2016 |
Estimated Primary Completion Date : | July 2021 |
Estimated Study Completion Date : | October 2021 |

Group/Cohort | Intervention/treatment |
---|---|
Laser Therapy
Participants will receive laser therapy for the treatment of their hypertrophic burn scars. Laser treatment decisions will be tailored to meet the needs of the patient.
|
Device: Laser Therapy
Laser therapy is a technology that can be used to treat hypertrophic burn scars. |
- Vancouver Scar Scale Score [ Time Frame: Baseline (month 0) to month 12 ]
The Vancouver Scar Scale is composed of four subscales which include pigmentation (range: 0 - 3), vascularity (range: 0 - 3), pliability (range: 0 - 5), and height (range: 0 - 3).
Total Vancouver Scar Scale score refers to the score obtained by summing the values from each subscale (range: 0 - 14) with higher scores indicating a worse scar.
- Patient and Observer Scar Assessment Scale Score [ Time Frame: Baseline (month 0) to month 12 ]The Patient and Observer Scar Assessment Scale consists of two independent scales: 1) the patient scale (patient-reported), and 2) the observer scale (clinician-reported). Both the patient scale as well as the observer scale include a set of individual subscales that assess scar severity (range: 1 - 10) with higher scores indicating a worse scar.
- Scar thickness [ Time Frame: Baseline(month 0) to month 12 ]Scar thickness measurements will be taken at five study visits over the course of one year and will be measured using ultrasonography.
- Scar stiffness measured by the DermaLab Combo® skin analysis device [ Time Frame: Baseline(month 0) to month 12 ]Scar stiffness measurements will be taken at five study visits over the course of one year and will be measured using the DermaLab Combo® skin analysis device (Cortex Technologies, Hadsund, DK).
- Scar stiffness measured by ultrasound elastographgy [ Time Frame: Baseline(month 0) to month 12 ]Scar stiffness measurements will be taken at five study visits over the course of one year and will be measured using ultrasound elastography.
- Scar colour [ Time Frame: Baseline(month 0) to month 12 ]Scar colour measurements will be taken at five study visits over the course of one year and will be measured using the DermaLab Combo® skin analysis device (Cortex Technologies, Hadsund, DK)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 1 Year to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Age 1-18 years at presentation
- Patients with a hypertrophic burn scar that has been clinically diagnosed by a burn care specialist
- Hypertrophic burn scar resulting from any etiology
- Hypertrophic burn scar is ≥ 2 months post healing
- Ability to complete English- language questionnaires
Exclusion Criteria:
- Patients with concomitant skin disease (i.e. chronic skin conditions, herpes infection)
- Patients with a history of keloid scarring
- Patients who cannot tolerate the intravenous (IV) sedation used to perform laser therapy procedures
- Patients who have had previous laser therapy procedures

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02707627
Contact: Jennifer Zuccaro | 416-813-7654 ext 203018 | jennifer.zuccaro@sickkids.ca |
Canada, Ontario | |
Hospital for Sick Children | Recruiting |
Toronto, Ontario, Canada, M5G1X8 | |
Contact: Jennifer Zuccaro 4168137654 ext 203018 jennifer.zuccaro@sickkids.ca |
Responsible Party: | Joel Fish, Medical Director, Burn Program, The Hospital for Sick Children |
ClinicalTrials.gov Identifier: | NCT02707627 |
Other Study ID Numbers: |
Hospital for Sick Children |
First Posted: | March 14, 2016 Key Record Dates |
Last Update Posted: | November 20, 2020 |
Last Verified: | November 2020 |
Pediatric Laser Burn Scar Photothermolysis |
Cicatrix Cicatrix, Hypertrophic Burns |
Wounds and Injuries Fibrosis Pathologic Processes |